| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.3 | 0.05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |